The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: Evidence that androgens impair insulin action in women

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 3, 1996, Pages 952-960

  Moghetti, Paolo ^a,b   Tosi, Flavia ^a   Castello, Roberto ^a   Magnani, Chiara M ^a   Negri, Carlo ^a   Brun, Elisabetta ^a   Furlani, Lino ^a   Caputo, Marco ^b   Muggeo, Michele ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; BUSERELIN; FLUTAMIDE; GLUCOSE; GONADORELIN AGONIST; INSULIN; SPIRONOLACTONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADULT; ANDROGEN ANTAGONISTS; ANDROGENS; BUSERELIN; FEMALE; FLUTAMIDE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERANDROGENISM; INSULIN; INSULIN RESISTANCE; OVULATION; SPIRONOLACTONE;

EID: 0029863959     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.3.952     Document Type: Article

References (76)

1. Poretsky L. 1991 On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev. 12:3-13.
2. Taylor SI, Dons RF, Hernandez E, Roth J, Gorden P. 1982 Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. Ann Intern Med. 97:851-855.
3. Richards GE, Cavallo A, Meyer III WJ, et al. 1985 Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history. J Pediatr. 107:893-897.
4. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. 1986 Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 62:904-910.
5. Geffner ME, Golde DW. 1988 Selective insulin action on skin, ovary, and heart in insulin-resistant states. Diabetes Care. 11:500-505.
6. Nestler JE, Barlascini CO, Matt DW, et al. 1989 Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 68:1027-1032.
7. DeClue TJ, Shah SC, Marchese M, Malone JI. 1991 Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female. J Clin Endocrinol Metab. 72:1308-1311.
8. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism. 43:647-654.
9. Givens JR, Kerber IJ, Wiser WL, Andersen RN, Coleman SA, Fish SA. 1974 Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma. J Clin Endocrinol Metab. 38:347-355.
10. Woodard TL, Burghen GA, Kitabchi AE, Wilimas JA. 1981 Glucose intolerance and insulin resistance in aplastic anemia treated with oxymetholone. J Clin Endocrinol Metab. 53:915-918.
11. Cohen JC, Hickman R. 1987 Insulin resistance and diminished glucose tolerance powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab. 64: 960-963.
12. Holmang A, Svedberg J, Jennische E, Bjorntorp P. 1990 Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am J Physiol. 259:E555-E560.
13. Pasquali R, Casimirri F, Balestra V, et al. 1991 The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women. J Endocrinol Invest. 14:839-846.
14. Laws A, Reaven GM. 1993 Insulin resistance and risk factors for coronary heart disease. In: Ferrannini E, ed. Bailliere's clinical endocrinology and metabolism: insulin resistance and disease. London: Bailliere Tindall; vol 7:1063-1078.
15. Wild RA, Grubb BG, Hartz A, VanNort JJ, Bachman W, Bartholomew M. 1990 Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril. 54:255-259.
16. Dunaif A, Graf M, Mandeli J, Laumas V, A. Dobrjansky. 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 65:499-507.
17. Geffner ME, Kaplan SA, Bersch N, Golde DW, Landaw EM, Chang RJ. 1986 Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion. Fertil Steril. 45:327-333.
18. Dunaif A, Green G, Futterweit W, Dobrjansky A. 1990 Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 70:699-704.
19. Dale PO, Tanbo T, Djoseland O, Jervell J, Abyholm T. 1992 Persistence of hyperinsulinemia in polycystic ovary syndrome after ovarian suppression by gonadotropin-releasing hormone agonist. Acta Endocrinol (Copenh). 126:132-136.
20. Elkind-Hirsch KE, Valdes CT, Malinak LR. 1993 Insulin resistance improves in hyperandrogenic women treated with Lupron. Fertil Steril. 60:634-641.
21. Shoupe D, Lobo RA. 1984 The influence of androgens on insulin resistance. Fertil Steril. 41:385-388.
22. Wild RA, Demers LM, Applebaum-Bowden D, Lenker R. 1991 Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Contraception. 44:113-124.
23. Mortola JF, Yen SSC. 1990 The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 71:696-704.
24. Polderman KH, Gooren LJG, Asscheman H, Bakker A, Heine RJ. 1994 Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab. 79:265-271.
25. DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:E214-E223.
26. Dunaif A. 1992 Diabetes mellitus and polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Current issues in endocrinology and metabolism: polycystic ovary syndrome. Boston: Blackwell; 347-358.
27. National Diabetes Data Group. 1979 Classification and diagnosis of diabetes mellitus and other diagnostic categories of glucose intolerance. Diabetes. 28: 1039-1057.
28. WHO Study Group. 1985 Diabetes mellitus. WHO Tech Rep Ser. 727:1-113.
29. Bardin CW, Lipsett MB. 1967 Testosterone and androstenedione production rates in normal women and women in idiopathic hirsutism or polycystic ovaries. J Clin Invest. 46:891-902.
30. Kirschner MA, Zucker IR, Jespersen D. 1976 Idiopathic hirsutism - an ovarian abnormality. N Engl J Med. 294:637-640.
31. Hatch R, Rosenfield RL, Kim MH, Tredway D. 1981 Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 140:815-830.
32. Rosenfield RL, Ehrmann DA, Barnes RB, Sheikh Z. 1993 Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann NY Acad Sci 687:162-181.
33. Castello R, Moghetti P, Zardini G, et al. Ability of the GnRH-agonist stimulation test in the diagnosis of polycystic ovary syndrome [Abstract]. Proc of the Int Symp on Intraovarian Regulators and Polycystic Ovarian Syndrome. 1992; 70.
34. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 327:157-162.
35. Bonora E, Moghetti P, Zancanaro C, et al. 1989 Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab. 68:374-378.
36. Ferrannini E. 1988 The theoretical bases of indirect calorimetry: a review. Metabolism. 37:287-301.
37. DeFronzo RA. 1988 The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 37:667-687.
38. Gray DS, Bray GA, Gemayel N, Kaplan K. 1989 Effect of obesity on bioelectrical impedance. Am J Clin Nutr. 50:255-260.
39. Somogyi M. 1945 Determination of blood sugar. J Biol Chem. 160:69-73.
40. Steele R, Wall JS, DeBodo RC, Altszuler N. 1956 Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol. 187:15-25.
41. Michel G, Baulieu EE. 1980 Androgen receptor in rat skeletal muscle: characterization and physiological variations. Endocrinology. 107:2088-2098.
42. Paik S-G, Michelis MA, Kim YT, Shin S. 1982 Induction of insulin-dependent diabetes by streptozotocin: inhibition by estrogens and potentiation by androgens. Diabetes. 31:724-729.
43. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. 1983 Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 57:304-310.
44. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. 1983 Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest. 72:1150-1162.
45. Yki-Jarvinen H. 1984 Sex and insulin sensitivity. Metabolism. 33:1011-1015.
46. Xu X, De Pergola G, Bjorntorp P. 1990 The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology. 126:1229-1234.
47. Bjorntorp P. 1991 Metabolic implications of body fat distribution. Diabetes Care. 14:1132-1143.
48. Forbes GB, Porta CR, Herr BE, Griggs RC. 1992 Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA. 267:397-399.
49. Krakower GR, Meier DA, Kissebah AH. 1993 Female sex hormones, perinatal, and peripubertal androgenization on hepatocyte insulin dynamics in rats. Am J Physiol. 264:E342-E347.
50. Nestler JE, Barlascini CO, Clore JN, Blackard WG. 1988 Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 66:57-61.
51. Friedl KE, Jones RE, Hannan CJ, Plymate SR. 1989 The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance. J Clin Endocrinol Metab. 68:971-975.
52. Bergman RN, Finegood DT, Ader M. 1985 Assessment of insulin sensitivity in vivo. Endocr Rev. 6:45-86.
53. Givens JR. 1985 Treatment of hirsutism with spironolactone. Fertil Steril. 43:841-843.
54. McMullen GR, Van Herle AJ. 1993 Hirsutism and the effectiveness of spironolactone in its management. J Endocrinol Invest. 16:925-932.
55. Cusan L, Dupont A, Gomez JL, Tremblay RR, Labrie F. 1994 Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertil Steril. 61:281-287.
56. Ayub M, Levell MJ. 1987 Inhibition of rat testicular 17α-hydroxylase and 17,20-lyase activities by anti-androgens (flutamide, hydroxyflutamide, RU23908, cyproterone acetate) in vitro. J Steroid Biochem. 28:43-47.
57. Brochu M, Belanger A, Dupont A, Cusan L, Labrie F. 1987 Effects of flutamide and aminoglutethimide on plasma 5α-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate. J Steroid Biochem. 28:619-622.
58. Moghetti P, Castello R, Negri C, et al. 1995 Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes and androgen receptor behavior. Fertil Steril. 64:511-517.
59. Rittmaster RS. 1993 Use of gonadotropin-releasing hormone agonists in the treatment of hyperandrogenism. Clin Obstet Gynecol. 36:679-689.
60. Filicori M, Flamigni C. 1988 GnRH agonists and antagonists: a review of their current status. Drugs. 35:63-82.
61. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1165-1174.
62. Peiris AN, Aiman EJ, Drucker WD, A. H. Kissebah. 1989 The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women. J Clin Endocrinol Metab. 68:715-720.
63. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P. 1994 Testosterone concentrations in women and men with NIDDM. Diabetes Care. 17: 405-411.
64. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. 1983 Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 57:356-359.
65. Simon D, Preziosi P, Barret-Connor E, et al. 1992 Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom study. Diabetologia. 35:173-177.
66. Haffner SM, Karhapaa P, Mykkanen L, M. Laakso. 1994 Insulin resistance, body fat distribution, and sex hormones in men. Diabetes. 43:212-219.
67. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary sindrome. Diabetes. 41:1257-1266.
68. Jialal I, Naiker P, Reddi K, Moodley J, Joubert SM. 1987 Evidence for insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 64:1066-1069.
69. Grulet H, Hecart AC, Delemer B, et al. 1993 Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol (Oxf). 38:621-626.
70. Robinson S, Chan S-P, Spacey S, Anyaoku V, Johnston DG, Franks S. 1992 Postprandial termogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol (Oxf). 36:537-543.
71. Robinson S, Kiddy D, Gelding SV, et al. 1993 The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf). 39:351-355.
72. Ovesen P, Moller J, Ingerslev HJ, et al. 1993 Normal basal and insulin-stimulated fuel metabolism in lean women with polycystic ovary syndrome. J Clin Endocrinol Metab. 77:1636-1640.
73. Holte J, Bergh T, Berne C, Berglund L, Lithell H. 1994 Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 78: 1052-1058.
74. Anttila L, Ying-Qing Ding MB, Ruutiainen K, Erkkola R, Irjala K, Huhtaniemi I. 1991 Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease. Fertil Steril. 55:1057-1061.
75. Dunaif A, Sorbara L, Delson R, Green G. 1993 Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes. 42:1462-1468.
76. Ciaraldi TP, El-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SSC. 1992 Cellular mechanisms of insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 75:577-583.